Pharma's $100B Bet: Avoiding Tariffs, Boosting US Production

Pharma Flurry: Trump-Era Tariff Threat Triggers $100s of Billions in US Drugmaker Investments! Facing potential 100% tariffs, Pfizer, AstraZeneca, Roche, and others are pumping billions into American manufacturing and R&D. Discover how this tariff scare is reshaping the pharmaceutical landscape, driving new plants, jobs, and strategies to protect drug supplies and prices. Is this a short-term scramble or a permanent shift? Find out now!The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.